Business Segments · Total Assets
Diagnostics and Genomics — Total Assets
Agilent Technologies Diagnostics and Genomics — Total Assets increased by 26.5% to $5.04B in Q3 2024 compared to the prior quarter. Year-over-year, this metric grew by 27.2%, from $3.97B to $5.04B. Over 3 years (FY 2021 to FY 2024), Diagnostics and Genomics — Total Assets shows an upward trend with a 11.0% CAGR.
Analysis
StatementSegment
CategoryCapital Allocation
SignalContext dependent
VolatilityModerate
First reportedQ4 2022
Last reportedQ1 2026
Rolls up toTotal Assets
How to read this metric
An increase indicates expansion of the asset base, which should ideally be accompanied by proportional growth in revenue and operating income.
Detailed definition
This represents the sum of all current and non-current assets controlled by the diagnostics and genomics segment, includ...
Peer comparison
Standard balance sheet metric used to evaluate the scale and capital requirements of a business segment.
Metric ID:
a_segment_diagnostics_and_genomics_total_assetsHistorical Data
15 periods
| Q1 '21 | Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $3.26B | $3.28B | $3.32B | $3.33B | $3.38B | $3.45B | $3.49B | $3.52B | $3.55B | $3.26B | $3.97B | $3.96B | $3.98B | $3.99B | $5.04B |
| QoQ Change | — | +0.5% | +1.3% | +0.2% | +1.8% | +1.8% | +1.3% | +0.9% | +0.8% | -8.3% | +21.8% | -0.1% | +0.4% | +0.2% | +26.5% |
| YoY Change | — | — | — | — | +3.7% | +5.1% | +5.1% | +5.9% | +4.9% | -5.5% | +13.7% | +12.6% | +12.1% | +22.5% | +27.2% |
Range$3.26B – $5.04B
CAGR+13.3%
Avg YoY Growth+9.7%
Median YoY Growth+5.9%
Current Streak3 quarters growth
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Agilent Technologies's diagnostics and genomics — total assets?
- Agilent Technologies (A) reported diagnostics and genomics — total assets of $5.04B in Q3 2024.
- How has Agilent Technologies's diagnostics and genomics — total assets changed year-over-year?
- Agilent Technologies's diagnostics and genomics — total assets increased by 27.2% year-over-year, from $3.97B to $5.04B.
- What is the long-term trend for Agilent Technologies's diagnostics and genomics — total assets?
- Over 3 years (2021 to 2024), Agilent Technologies's diagnostics and genomics — total assets has grown at a 11.0% compound annual growth rate (CAGR), from $12.40B to $16.97B.
- What does diagnostics and genomics — total assets mean?
- The total value of all resources and assets owned by the diagnostics and genomics segment.